An Open-label, Dose Escalation Study to Assess the Pharmacokinetics of of ASA404 in Adult Cancer Patients With Impaired Hepatic Function

Clinical trial NCT01278849 · TERMINATED

Trial details

NCT number

NCT01278849

Sponsor

Novartis Pharmaceuticals

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2010-01-01

Primary completion

2010-11-01

Enrollment

5

View on ClinicalTrials.gov